BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang TH, Huang PI, Hu YW, Lin KH, Liu CS, Lin YY, Liu CA, Tseng HS, Liu YM, Lee RC. Combined Yttrium-90 microsphere selective internal radiation therapy and external beam radiotherapy in patients with hepatocellular carcinoma: From clinical aspects to dosimetry. PLoS One 2018;13:e0190098. [PMID: 29293557 DOI: 10.1371/journal.pone.0190098] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Elbanna M, Chowdhury NN, Rhome R, Fishel ML. Clinical and Preclinical Outcomes of Combining Targeted Therapy With Radiotherapy. Front Oncol 2021;11:749496. [PMID: 34733787 DOI: 10.3389/fonc.2021.749496] [Reference Citation Analysis]
2 Patel R, Roberson J, Prakash D, Meyer R, Hogan L, Azmy C, Suprenant V, Ryu S, Stessin A. Potential alternative treatment approach for pediatric patient with diffusely infiltrative primary rhabdomyosarcoma of the liver. Rep Pract Oncol Radiother 2021;26:143-8. [PMID: 34046225 DOI: 10.5603/RPOR.a2021.0008] [Reference Citation Analysis]
3 Wallace MC, Sek K, Francis RJ, Samuelson S, Ferguson J, Tibballs J, Asad A, Preen DB, MacQuillan G, Garas G, Adams LA, Jeffrey GP. Baseline and Post-treatment 18F-Fluorocholine PET/CT Predicts Outcomes in Hepatocellular Carcinoma Following Locoregional Therapy. Dig Dis Sci 2020;65:647-57. [PMID: 31440998 DOI: 10.1007/s10620-019-05781-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
4 Kao YH. Dose-response for yttrium-90 resin microsphere radioembolisation. Nucl Med Commun 2021;42:345-7. [PMID: 33346604 DOI: 10.1097/MNM.0000000000001351] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Lin KH, Chen YW, Lee RC, Wang LW, Chou FI, Chang CW, Yen SH, Huang WS. Nuclear Theranostics in Taiwan. Nucl Med Mol Imaging 2019;53:86-91. [PMID: 31057678 DOI: 10.1007/s13139-019-00576-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
6 Yu Q, Liu C, Pillai A, Ahmed O. Twenty Years of Radiation Therapy of Unresectable Intrahepatic Cholangiocarinoma: Internal or External? A Systematic Review and Meta-Analysis. Liver Cancer 2021;10:433-50. [PMID: 34721506 DOI: 10.1159/000516880] [Reference Citation Analysis]
7 Underhill GH, Khetani SR. Emerging trends in modeling human liver disease in vitro. APL Bioeng 2019;3:040902. [PMID: 31893256 DOI: 10.1063/1.5119090] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
8 Gulec SA, Mcgoron AJ. Radiomicrosphere Dosimetry: Principles and Current State of the Art. Seminars in Nuclear Medicine 2022. [DOI: 10.1053/j.semnuclmed.2021.12.009] [Reference Citation Analysis]
9 Franzese C, Comito T, Viganò L, Pedicini V, Franceschini D, Clerici E, Loi M, Donadon M, Poretti D, Solbiati L, Torzilli G, Scorsetti M. Liver Metastases-directed Therapy in the Management of Oligometastatic Breast Cancer. Clin Breast Cancer 2020;20:480-6. [PMID: 32631769 DOI: 10.1016/j.clbc.2020.05.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Freudenberg R, Hartmann H, Andreeff M, Oehme L, Leichtner T, Fischer A, Paulus T, Krause M, Kotzerke J. [Treatment Planning and Dose Verification for Combined Internal and External Radiotherapy (CIERT)]. Nuklearmedizin 2021. [PMID: 34844272 DOI: 10.1055/a-1650-9428] [Reference Citation Analysis]
11 Skanjeti A, Magand N, Defez D, Tordo J, Rode A, Manichon AF, Hallouard F, Clave-Darcissac C, Dhomps A, Townsend DM, Rubello D, Giammarile F. Selective internal radiation therapy of hepatic tumors: Morphologic and functional imaging for voxel-based computer-aided dosimetry. Biomed Pharmacother 2020;132:110865. [PMID: 33254427 DOI: 10.1016/j.biopha.2020.110865] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Tong VJW, Shelat VG, Chao YK. Clinical application of advances and innovation in radiation treatment of hepatocellular carcinoma. J Clin Transl Res 2021;7:811-33. [PMID: 34988334] [Reference Citation Analysis]
13 Abbott E, Young RS, Hale C, Mitchell K, Falzone N, Vallis KA, Kennedy A. Stereotactic Inverse Dose Planning After Yttrium-90 Selective Internal Radiation Therapy in Hepatocellular Cancer. Adv Radiat Oncol 2021;6:100617. [PMID: 33912733 DOI: 10.1016/j.adro.2020.11.002] [Reference Citation Analysis]